Another study also confirmed that the combination of NM sensitized oxaliplatin-induced NF-κB/p65 activation via suppressing phosphorylated IκBα and IKKα/β in colorectal cancer, resulting in reduced cell proliferation, increased apoptosis in vitro and decreased tumor growth in vivo (15). This evidence concerns the gene NFKB1 and neoplasm.